Metronomic Chemotherapy: A Systematic Review of the Literature and Clinical Experience
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Metronomic Chemotherapy: A Systematic Review of the Literature and Clinical Experience
Authors
Keywords
-
Journal
Journal of Oncology
Volume 2019, Issue -, Pages 1-31
Publisher
Hindawi Limited
Online
2019-03-21
DOI
10.1155/2019/5483791
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Metronomic vinorelbine is directly active on Non Small Cell Lung Cancer cells and sensitizes the EGFRL858R/T790M cells to reversible EGFR tyrosine kinase inhibitors
- (2018) Paola Orlandi et al. BIOCHEMICAL PHARMACOLOGY
- Does metronomic chemotherapy induce tumor angiogenic dormancy? A review of available preclinical and clinical data
- (2018) Gianfranco Natale et al. CANCER LETTERS
- Phase I Trial of Veliparib, a Poly ADP Ribose Polymerase Inhibitor, Plus Metronomic Cyclophosphamide in Metastatic HER2-negative Breast Cancer
- (2018) Jesus Anampa et al. Clinical Breast Cancer
- Phase I/II Trial of Combined Pegylated Liposomal Doxorubicin and Cyclophosphamide in Metastatic Breast Cancer
- (2018) Amy E. Chang et al. Clinical Breast Cancer
- Durable Complete Response of Hepatocellular Carcinoma after Metronomic Capecitabine
- (2018) Giovanni Brandi et al. TUMORI
- Pazopanib (GW786034) and cyclophosphamide in patients with platinum-resistant, recurrent, pre-treated ovarian cancer - Results of the PACOVAR-trial
- (2017) C. Dinkic et al. GYNECOLOGIC ONCOLOGY
- Retrospective analysis of palliative metronomic chemotherapy in head and neck cancer
- (2017) K Prabhash et al. INDIAN JOURNAL OF CANCER
- Pilot phase II study of metronomic chemotherapy in combination with bevacizumab in patients with advanced non-squamous non-small cell lung cancer
- (2017) Benjamin S. Jones et al. LUNG CANCER
- Retrospective analysis of palliative metronomic chemotherapy in head and neck cancer
- (2017) K Prabhash et al. INDIAN JOURNAL OF CANCER
- A metronomic schedule as salvage chemotherapy for upper gastrointestinal tract cancer
- (2016) Michela Roberto et al. ANTI-CANCER DRUGS
- Efficacy of metronomic oral cyclophosphamide with low dose dexamethasone and celecoxib in metastatic castration-resistant prostate cancer
- (2016) Yumun Jeong et al. Asia-Pacific Journal of Clinical Oncology
- Phase 1/2 study of lenalidomide combined with low-dose cyclophosphamide and prednisone in lenalidomide-refractory multiple myeloma
- (2016) I. S. Nijhof et al. BLOOD
- Metronomic chemotherapy with oral vinorelbine (mVNR) and capecitabine (mCAPE) in advanced HER2-negative breast cancer patients: is it a way to optimize disease control? Final results of the VICTOR-2 study
- (2016) M. E. Cazzaniga et al. BREAST CANCER RESEARCH AND TREATMENT
- Clinical, pharmacodynamic and pharmacokinetic results of a prospective phase II study on oral metronomic vinorelbine and dexamethasone in castration-resistant prostate cancer patients
- (2016) Teresa Di Desidero et al. INVESTIGATIONAL NEW DRUGS
- Pharmacokinetics of metronomic chemotherapy: a neglected but crucial aspect
- (2016) Guido Bocci et al. Nature Reviews Clinical Oncology
- A randomized study of KRAS-guided maintenance therapy with bevacizumab, erlotinib or metronomic capecitabine after first-line induction treatment of metastatic colorectal cancer: the Nordic ACT2 trial
- (2015) H. Hagman et al. ANNALS OF ONCOLOGY
- Evaluation of low-dose thalidomide as induction and maintenance therapy in patients with multiple myeloma not eligible for stem cell transplantation
- (2015) Mozaffar Aznab et al. Asia-Pacific Journal of Clinical Oncology
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Cisplatin in combination with metronomic vinorelbine as front-line treatment in advanced non-small cell lung cancer: a multicenter phase II study of the Hellenic Oncology Research Group (HORG)
- (2015) P. Katsaounis et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Lenalidomide and cyclophosphamide immunoregulation in patients with metastatic, castration-resistant prostate cancer
- (2015) J. Wang et al. CLINICAL & EXPERIMENTAL METASTASIS
- Phase II Study With Epirubicin, Cisplatin, and Infusional Fluorouracil Followed by Weekly Paclitaxel With Metronomic Cyclophosphamide as a Preoperative Treatment of Triple-Negative Breast Cancer
- (2015) Giuseppe Cancello et al. Clinical Breast Cancer
- New Treatment Options for Patients With Metastatic Prostate Cancer: What Is The Optimal Sequence?
- (2015) Joyce M. van Dodewaard-de Jong et al. Clinical Genitourinary Cancer
- Cisplatin, Etoposide, and Bevacizumab Regimen Followed by Oral Etoposide and Bevacizumab Maintenance Treatment in Patients With Extensive-Stage Small Cell Lung Cancer: A Single-Institution Experience
- (2015) Roberto Petrioli et al. Clinical Lung Cancer
- Metronomic capecitabine as second-line treatment in hepatocellular carcinoma after sorafenib failure
- (2015) Alessandro Granito et al. DIGESTIVE AND LIVER DISEASE
- Weekly ixabepilone with or without biweekly bevacizumab in the treatment of recurrent or persistent uterine and ovarian/primary peritoneal/fallopian tube cancers: A retrospective review
- (2015) Dana M. Roque et al. GYNECOLOGIC ONCOLOGY
- Interferon Alpha and Metronomic Cyclophosphamide for Metastatic Kidney Cancer: A Phase 2 Study
- (2015) Krzysztof Tupikowski et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Maintenance treatment with capecitabine and bevacizumab in metastatic colorectal cancer (CAIRO3): a phase 3 randomised controlled trial of the Dutch Colorectal Cancer Group
- (2015) Lieke H J Simkens et al. LANCET
- Metronomic vinorelbine (oral) in combination with sorafenib in advanced non-small cell lung cancer
- (2015) Eng Huat Tan et al. LUNG CANCER
- SHARPIN overexpression induces tumorigenesis in human prostate cancer LNCaP, DU145 and PC-3 cells via NF-κB/ERK/Akt signaling pathway
- (2015) Jin Li et al. MEDICAL ONCOLOGY
- Continuous, low-dose capecitabine for patients with recurrent colorectal cancer
- (2015) Adriana Romiti et al. MEDICAL ONCOLOGY
- Efficacy of Oral Etoposide in Pretreated Metastatic Breast Cancer
- (2015) Peng Yuan et al. MEDICINE
- On and off Metronomic Oral Vinorelbine in Elderly Women with Advanced Breast Cancer
- (2015) Francesca De Iuliis et al. TUMORI
- Potent efficacy of metronomic topotecan and pazopanib combination therapy in preclinical models of primary or late stage metastatic triple-negative breast cancer
- (2015) Teresa Di Desidero et al. Oncotarget
- Endothelial Progenitor Cells in Tumor Angiogenesis: Another Brick in the Wall
- (2015) Marina Marçola et al. Stem Cells International
- On and off Metronomic Oral Vinorelbine in Elderly Women with Advanced Breast Cancer
- (2015) Francesca De Iuliis et al. TUMORI JOURNAL
- A Review of Novel Therapies for Melanoma
- (2014) Chante Karimkhani et al. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- A systematic literature analysis of correlative studies in low-dose metronomic chemotherapy trials
- (2014) Gemma Cramarossa et al. Biomarkers in Medicine
- Combination of letrozole, metronomic cyclophosphamide and sorafenib is well-tolerated and shows activity in patients with primary breast cancer
- (2014) L Bazzola et al. BRITISH JOURNAL OF CANCER
- Phase I-II trial of oral cyclophosphamide, prednisone and lenalidomide for the treatment of patients with relapsed and refractory multiple myeloma
- (2014) Donna E. Reece et al. BRITISH JOURNAL OF HAEMATOLOGY
- Docetaxel plus oral metronomic cyclophosphamide: A phase II study with pharmacodynamic and pharmacogenetic analyses in castration-resistant prostate cancer patients
- (2014) Lisa Derosa et al. CANCER
- Metronomic Oral Cyclophosphamide Chemotherapy Possibly Contributes to Stabilization of Disease in Patients With Metastatic Castration-Resistant Prostate Cancer: A Prospective Analysis of Consecutive Cases
- (2014) Masahiro Yashi et al. Clinical Genitourinary Cancer
- Bevacizumab in Combination with Metronomic Chemotherapy in Patients with Anthracycline- and Taxane-Refractory Breast Cancer
- (2014) J.A. García-Sáenz et al. JOURNAL OF CHEMOTHERAPY
- Oral Metronomic Chemo-Hormonal-Therapy of Metastatic Breast Cancer with Cyclophosphamide and Megestrol Acetate
- (2014) A. Licchetta et al. JOURNAL OF CHEMOTHERAPY
- Bevacizumab Combined With Chemotherapy for Platinum-Resistant Recurrent Ovarian Cancer: The AURELIA Open-Label Randomized Phase III Trial
- (2014) Eric Pujade-Lauraine et al. JOURNAL OF CLINICAL ONCOLOGY
- Continuous low-dose cyclophosphamide and prednisone in the treatment of relapsed/refractory multiple myeloma with severe heart failure
- (2014) Fan Zhou et al. LEUKEMIA & LYMPHOMA
- Anti-Bv8 Antibody and Metronomic Gemcitabine Improve Pancreatic Adenocarcinoma Treatment Outcome Following Weekly Gemcitabine Therapy
- (2014) Erez Hasnis et al. NEOPLASIA
- Oral Etoposide for Platinum-Resistant and Recurrent Epithelial Ovarian Cancer: a Study by the Anatolian Society of Medical Oncology
- (2013) Mehmet Kucukoner et al. Asian Pacific Journal of Cancer Prevention
- VEGF-A polymorphisms predict progression-free survival among advanced castration-resistant prostate cancer patients treated with metronomic cyclophosphamide
- (2013) P Orlandi et al. BRITISH JOURNAL OF CANCER
- Breast cancer statistics, 2013
- (2013) Carol DeSantis et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Low dose capecitabine plus weekly paclitaxel in patients with metastatic breast cancer: a multicenter phase II study KBCSG-0609
- (2013) Tetsuya Taguchi et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Heterogeneity of tumor endothelial cells
- (2013) Kyoko Hida et al. CANCER SCIENCE
- Phase II Trial of Fulvestrant With Metronomic Capecitabine for Postmenopausal Women With Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer
- (2013) Lee S. Schwartzberg et al. Clinical Breast Cancer
- Low-dose metronomic chemotherapy: A systematic literature analysis
- (2013) K. Lien et al. EUROPEAN JOURNAL OF CANCER
- Safety and therapeutic effect of metronomic chemotherapy with cyclophosphamide and celecoxib in advanced breast cancer patients
- (2013) Herman A Perroud et al. Future Oncology
- Metronomic therapy is an effective salvage treatment for heavily pre-treated relapsed/refractory multiple myeloma
- (2013) X. Papanikolaou et al. HAEMATOLOGICA
- Efficacy and safety of metronomic administration of paclitaxel for advanced recurrent non-small-cell lung cancer
- (2013) K Prabhash et al. INDIAN JOURNAL OF CANCER
- Oral metronomic scheduling of anticancer therapy-based treatment compared to existing standard of care in locally advanced oral squamous cell cancers: A matched-pair analysis
- (2013) SD Banavali et al. INDIAN JOURNAL OF CANCER
- Metronomic weekly paclitaxel in advanced unresectable esophageal cancer
- (2013) K Prabhash et al. INDIAN JOURNAL OF CANCER
- Chemotherapy-induced immunogenic modulation of tumor cells enhances killing by cytotoxic T lymphocytes and is distinct from immunogenic cell death
- (2013) James W. Hodge et al. INTERNATIONAL JOURNAL OF CANCER
- Metronomic chemotherapy following the maximum tolerated dose is an effective anti-tumour therapy affecting angiogenesis, tumour dissemination and cancer stem cells
- (2013) Marta Vives et al. INTERNATIONAL JOURNAL OF CANCER
- Tumour endothelial cells acquire drug resistance in a tumour microenvironment
- (2013) K. Hida et al. JOURNAL OF BIOCHEMISTRY
- A phase II study of metronomic oral vinorelbine administered in the second line and beyond in non-small cell lung cancer (NSCLC): a phase II study of the Hellenic Oncology Research Group
- (2013) Emmanouil Kontopodis et al. JOURNAL OF CHEMOTHERAPY
- The combination of intravenous bevacizumab and metronomic oral cyclophosphamide is an effective regimen for platinum-resistant recurrent ovarian cancer
- (2013) Emma L. Barber et al. Journal of Gynecologic Oncology
- Oral etoposide and oral prednisone for the treatment of castration resistant prostate cancer
- (2013) Yi-Ping Zhu et al. KAOHSIUNG JOURNAL OF MEDICAL SCIENCES
- Has the time come for metronomics in low-income and middle-income countries?
- (2013) Nicolas André et al. LANCET ONCOLOGY
- Metronomic Capecitabine in Advanced Hepatocellular Carcinoma Patients: A Phase II Study
- (2013) G. Brandi et al. ONCOLOGIST
- Phase II clinical trial of metronomic chemotherapy with combined irinotecan and tegafur–gimeracil–oteracil potassium in metastatic and recurrent breast cancer
- (2013) Hiroko Otsuka et al. Breast Cancer
- Strange attractors: DAMPs and autophagy link tumor cell death and immunity
- (2013) W Hou et al. Cell Death & Disease
- Concentration- and schedule-dependent effects of chemotherapy on the angiogenic potential and drug sensitivity of vascular endothelial cells
- (2012) Eddy Pasquier et al. ANGIOGENESIS
- Clinical, pharmacokinetic and pharmacodynamic evaluations of metronomic UFT and cyclophosphamide plus celecoxib in patients with advanced refractory gastrointestinal cancers
- (2012) Giacomo Allegrini et al. ANGIOGENESIS
- Combination antiangiogenic therapy in advanced breast cancer: a phase 1 trial of vandetanib, a VEGFR inhibitor, and metronomic chemotherapy, with correlative platelet proteomics
- (2012) Erica L. Mayer et al. BREAST CANCER RESEARCH AND TREATMENT
- Oral Metronomic Cyclophosphamide and Methotrexate Plus Fulvestrant in Advanced Breast Cancer Patients: A Mono-Institutional Case-Cohort Report
- (2012) Gaetano Aurilio et al. Breast Journal
- Metronomic oral combination chemotherapy with capecitabine and cyclophosphamide: a phase II study in patients with HER2-negative metastatic breast cancer
- (2012) Masataka Yoshimoto et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Protracted low dose of oral vinorelbine and temozolomide with whole-brain radiotherapy in the treatment for breast cancer patients with brain metastases
- (2012) Raffaele Addeo et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Metastatic melanoma patients treated with dendritic cell vaccination, Interleukin-2 and metronomic cyclophosphamide: results from a phase II trial
- (2012) Eva Ellebaek et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Can Targeted Therapy be Successful without Metronomic Scheduling ?
- (2012) Nicolas Andre et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- The efficacy of temozolomide for recurrent glioblastoma multiforme
- (2012) Chao Chen et al. EUROPEAN JOURNAL OF NEUROLOGY
- Phase II trial of continuous low-dose temozolomide for patients with recurrent malignant glioma
- (2012) Antonio Omuro et al. NEURO-ONCOLOGY
- Efficacy, Safety, and Biomarkers of Single-Agent Bevacizumab Therapy in Patients with Advanced Hepatocellular Carcinoma
- (2012) V. Boige et al. ONCOLOGIST
- Efficacy, Safety, and Potential Biomarkers of Thalidomide plus Metronomic Chemotherapy for Advanced Hepatocellular Carcinoma
- (2012) Yu-Yun Shao et al. ONCOLOGY
- Phase II study of oral etoposide maintenance for patients with extensive stage small cell lung cancer who have responded to the induction on an EP regimen
- (2012) Lu Li et al. Thoracic Cancer
- Exploratory predictive and prognostic factors in advanced breast cancer treated with metronomic chemotherapy
- (2011) Manuela Miscoria et al. ANTI-CANCER DRUGS
- Phase II study of the combination carboplatin plus celecoxib in heavily pre-treated recurrent ovarian cancer patients
- (2011) Francesco Legge et al. BMC CANCER
- Pegylated liposomal doxorubicin in combination with low-dose metronomic cyclophosphamide as preoperative treatment for patients with locally advanced breast cancer
- (2011) Silvia Dellapasqua et al. BREAST
- Continuous low-dose cyclophosphamide and methotrexate combined with celecoxib for patients with advanced cancer
- (2011) O A Khan et al. BRITISH JOURNAL OF CANCER
- Combined weekly topotecan and biweekly bevacizumab in women with platinum-resistant ovarian, peritoneal, or fallopian tube cancer
- (2011) Kathryn F. McGonigle et al. CANCER
- Phase II trial of bevacizumab and dose/dense chemotherapy with cisplatin and metronomic daily oral etoposide in advanced non-small-cell-lung cancer patients
- (2011) Pierpaolo Correale et al. CANCER BIOLOGY & THERAPY
- A phase I trial of oral metronomic vinorelbine plus capecitabine in patients with metastatic breast cancer
- (2011) Zacharenia Saridaki et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- An all-oral combination of metronomic cyclophosphamide plus capecitabine in patients with anthracycline- and taxane-pretreated metastatic breast cancer: a phase II study
- (2011) Zhonghua Wang et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Human Tumor Cells Killed by Anthracyclines Induce a Tumor-Specific Immune Response
- (2011) J. Fucikova et al. CANCER RESEARCH
- Cancer Dormancy: A Model of Early Dissemination and Late Cancer Recurrence
- (2011) D. Paez et al. CLINICAL CANCER RESEARCH
- Feasibility of metronomic oral cyclophosphamide plus prednisolone in elderly patients with inoperable or metastatic soft tissue sarcoma
- (2011) Olivier Mir et al. EUROPEAN JOURNAL OF CANCER
- Sorafenib in combination with weekly topotecan in recurrent ovarian cancer, a phase I/II study of the Hoosier Oncology Group
- (2011) R. Ramasubbaiah et al. GYNECOLOGIC ONCOLOGY
- Cyclooxygenase-2 inhibition causes antiangiogenic effects on tumor endothelial and vascular progenitor cells
- (2011) Chikara Muraki et al. INTERNATIONAL JOURNAL OF CANCER
- Evaluation of oral chemotherapy with capecitabine and cyclophosphamide plus thalidomide and prednisone in prostate cancer patients
- (2011) Li-Juan Meng et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Regulatory T cell: a protection for tumour cells
- (2011) Yi Wang et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Pioglitazone, etoricoxib, interferon-α, and metronomic capecitabine for metastatic renal cell carcinoma: final results of a prospective phase II trial
- (2011) B. Walter et al. MEDICAL ONCOLOGY
- Capecitabine “metronomic” chemotherapy for palliative treatment of elderly patients with advanced gastric cancer after fluoropyrimidine-based chemotherapy
- (2011) ShengLi He et al. MEDICAL ONCOLOGY
- Phase II trial of low-dose continuous (metronomic) treatment of temozolomide for recurrent glioblastoma
- (2011) D.-S. Kong et al. NEURO-ONCOLOGY
- Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer
- (2011) Robert A. Burger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Drug-Tolerant Cancer Cells Show Reduced Tumor-Initiating Capacity: Depletion of CD44+ Cells and Evidence for Epigenetic Mechanisms
- (2011) Hong Yan et al. PLoS One
- Immunomodulatory effects of cyclophosphamide and implementations for vaccine design
- (2011) Antonella Sistigu et al. Seminars in Immunopathology
- Control Dominating Subclones for Managing Cancer Progression and Posttreatment Recurrence by Subclonal Switchboard Signal: Implication for New Therapies
- (2011) Shengwen Calvin Li et al. STEM CELLS AND DEVELOPMENT
- Salvage Therapy With Oral Metronomic Cyclophosphamide and Methotrexate for Castration-refractory Metastatic Adenocarcinoma of the Prostate Resistant to Docetaxel
- (2011) Vittorio Gebbia et al. UROLOGY
- Effective oral combination metronomic chemotherapy with low toxicity for the management of castration-resistant prostate cancer
- (2011) ÅSA JELLVERT et al. Experimental and Therapeutic Medicine
- Chemotherapeutic agents in low noncytotoxic concentrations increase immunogenicity of human colon cancer cells
- (2011) Ramon Kaneno et al. CELLULAR ONCOLOGY
- Bevacizumab and dose-intense temozolomide in recurrent high-grade glioma
- (2010) J. J. C. Verhoeff et al. ANNALS OF ONCOLOGY
- A phase 2 pilot trial of low-dose, continuous infusion, or “metronomic” paclitaxel and oral celecoxib in patients with metastatic melanoma
- (2010) Rupal S. Bhatt et al. CANCER
- 5-Fluorouracil Selectively Kills Tumor-Associated Myeloid-Derived Suppressor Cells Resulting in Enhanced T Cell-Dependent Antitumor Immunity
- (2010) J. Vincent et al. CANCER RESEARCH
- Low-Dose Metronomic Oral Administration of Vinorelbine in the First-line Treatment of Elderly Patients With Metastatic Breast Cancer
- (2010) Raffaele Addeo et al. Clinical Breast Cancer
- Continuous Administration of Low-Dose Cyclophosphamide and Prednisone as a Salvage Treatment for Multiple Myeloma
- (2010) Fan Zhou et al. Clinical Lymphoma Myeloma & Leukemia
- The growing diversity and spectrum of action of myeloid-derived suppressor cells
- (2010) Alberto Mantovani EUROPEAN JOURNAL OF IMMUNOLOGY
- Randomized phase III trial of tamoxifen versus thalidomide in women with biochemical-recurrent-only epithelial ovarian, fallopian tube or primary peritoneal carcinoma after a complete response to first-line platinum/taxane chemotherapy with an evaluation of serum vascular endothelial growth factor (VEGF): A Gynecologic Oncology Group Study
- (2010) Jean A. Hurteau et al. GYNECOLOGIC ONCOLOGY
- Retrospective Analysis of an Oral Combination of Dexamethasone, Uracil plus Tegafur and Cyclophosphamide for Hormone-refractory Prostate Cancer
- (2010) K. Hatano et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Phase II Trial of Continuous Dose-Intense Temozolomide in Recurrent Malignant Glioma: RESCUE Study
- (2010) James R. Perry et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II study of combining sorafenib with metronomic tegafur/uracil for advanced hepatocellular carcinoma
- (2010) Chih-Hung Hsu et al. JOURNAL OF HEPATOLOGY
- Continuous low-dose temozolomide and celecoxib in recurrent glioblastoma
- (2010) Florian Stockhammer et al. JOURNAL OF NEURO-ONCOLOGY
- Phase II study of metronomic chemotherapy with bevacizumab for recurrent glioblastoma after progression on bevacizumab therapy
- (2010) David A. Reardon et al. JOURNAL OF NEURO-ONCOLOGY
- METRONOMIC CYCLOPHOSPHAMIDE IN ELDERLY PATIENTS WITH ADVANCED, CASTRATION-RESISTANT PROSTATE CANCER
- (2010) Andrea Fontana et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Activity of a multitargeted chemo-switch regimen (sorafenib, gemcitabine, and metronomic capecitabine) in metastatic renal-cell carcinoma: a phase 2 study (SOGUG-02-06)
- (2010) Joaquim Bellmunt et al. LANCET ONCOLOGY
- Metronomic Gemcitabine in Combination with Sunitinib Inhibits Multisite Metastasis and Increases Survival in an Orthotopic Model of Pancreatic Cancer
- (2010) H. S. Tran Cao et al. MOLECULAR CANCER THERAPEUTICS
- Metronomic Chemotherapy Enhances Antitumor Effects of Cancer Vaccine by Depleting Regulatory T Lymphocytes and Inhibiting Tumor Angiogenesis
- (2010) Chi-An Chen et al. MOLECULAR THERAPY
- Metronomic chemotherapy: new rationale for new directions
- (2010) Eddy Pasquier et al. Nature Reviews Clinical Oncology
- EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer
- (2010) A Singh et al. ONCOGENE
- Bevacizumab plus Low-Dose Metronomic Oral Cyclophosphamide in Heavily Pretreated Patients with Recurrent Ovarian Cancer
- (2010) Alfonso Sánchez-Muñoz et al. ONCOLOGY
- Metronomic chemotherapy with daily, oral etoposide plus bevacizumab for recurrent malignant glioma: a phase II study
- (2009) D A Reardon et al. BRITISH JOURNAL OF CANCER
- Treg depletion with a low-dose metronomic temozolomide regimen in a rat glioma model
- (2009) Claire Banissi et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Dual Therapeutic Efficacy of Vinblastine as a Unique Chemotherapeutic Agent Capable of Inducing Dendritic Cell Maturation
- (2009) H. Tanaka et al. CANCER RESEARCH
- Cyclophosphamide induces bone marrow to yield higher numbers of precursor dendritic cells in vitro capable of functional antigen presentation to T cells in vivo
- (2009) Mohamed L. Salem et al. CELLULAR IMMUNOLOGY
- Clinical and Pharmacodynamic Evaluation of Metronomic Cyclophosphamide, Celecoxib, and Dexamethasone in Advanced Hormone-refractory Prostate Cancer
- (2009) A. Fontana et al. CLINICAL CANCER RESEARCH
- Oral metronomic cyclophosphamide in elderly with metastatic melanoma
- (2009) Estelle Borne et al. INVESTIGATIONAL NEW DRUGS
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2009) David Moher et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Randomized Phase II Trial of Chemoradiotherapy Followed by Either Dose-Dense or Metronomic Temozolomide for Newly Diagnosed Glioblastoma
- (2009) Jennifer L. Clarke et al. JOURNAL OF CLINICAL ONCOLOGY
- Oral Uracil and Tegafur Compared With Classic Cyclophosphamide, Methotrexate, Fluorouracil As Postoperative Chemotherapy in Patients With Node-Negative, High-Risk Breast Cancer: National Surgical Adjuvant Study for Breast Cancer 01 Trial
- (2009) Toru Watanabe et al. JOURNAL OF CLINICAL ONCOLOGY
- Oral UFT, etoposide and leucovorin in recurrent non-small cell lung cancer: A non-randomized phase II study
- (2009) V. Surmont et al. LUNG CANCER
- Oral second- and third-line lomustine–etoposide–cyclophosphamide chemotherapy for small cell lung cancer
- (2009) Bernard Lebeau et al. LUNG CANCER
- Clinical outcome of patients with docetaxel-resistant hormone-refractory prostate cancer treated with second-line cyclophosphamide-based metronomic chemotherapy
- (2009) Thomas Nelius et al. MEDICAL ONCOLOGY
- Continuous Administration of Daily Low-Dose Temozolomide in Pretreated Patients with Advanced Non-Small Cell Lung Cancer: A Phase II Study
- (2009) Charalambos Kouroussis et al. ONCOLOGY
- Anthracycline chemotherapy inhibits HIF-1 transcriptional activity and tumor-induced mobilization of circulating angiogenic cells
- (2009) K. Lee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Maximum tolerated dose: clinical endpoint for a bygone era?
- (2009) Chris H. Takimoto Targeted Oncology
- Oral low-dose dexamethasone for androgen-independent prostate cancer patients
- (2009) AKIRA KOMIYA et al. Oncology Letters
- A pharmacokinetic and pharmacodynamic study on metronomic irinotecan in metastatic colorectal cancer patients
- (2008) G Allegrini et al. BRITISH JOURNAL OF CANCER
- Phase 2 trial of temozolomide using protracted low-dose and whole-brain radiotherapy for nonsmall cell lung cancer and breast cancer patients with brain metastases
- (2008) Raffaele Addeo et al. CANCER
- Cancer chemotherapy: not only a direct cytotoxic effect, but also an adjuvant for antitumor immunity
- (2008) Cédric Ménard et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Combined oral cyclophosphamide and bevacizumab in heavily pre-treated ovarian cancer
- (2008) José Miguel Jurado García et al. Clinical & Translational Oncology
- Immunogenic cancer cell death: a key-lock paradigm
- (2008) Antoine Tesniere et al. CURRENT OPINION IN IMMUNOLOGY
- Judah Folkman's Contribution to the Inhibition of Angiogenesis
- (2008) Diane R. Bielenberg et al. Lymphatic Research and Biology
- A Pilot Study of Docetaxel and Trofosfamide as Second-Line ‘Metronomic’ Chemotherapy in the Treatment of Metastatic Non-Small Cell Lung Cancer (NSCLC)
- (2008) Michael Görn et al. ONKOLOGIE
- A prospective randomized trial of thalidomide with topotecan compared with topotecan alone in women with recurrent epithelial ovarian carcinoma
- (2007) Levi S. Downs et al. CANCER
- Phase II Clinical Trial of Bevacizumab and Low-Dose Metronomic Oral Cyclophosphamide in Recurrent Ovarian Cancer: A Trial of the California, Chicago, and Princess Margaret Hospital Phase II Consortia
- (2007) Agustin A. Garcia et al. JOURNAL OF CLINICAL ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More